Association of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors with Cardiovascular Events and Death in Dialysis Patients: A Systematic Review and Meta-Analysis.
透析患者中缺氧誘導因子脯氨酸羟化酶抑制劑與心血管事件和死亡的關聯:系統性回顧和荟萃分析。
Blood Purif 2023-09-13
An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease.
非透析依賴型慢性腎臟病貧血治療中促缺氧誘導因子脯氨酸羟化酶抑制劑的療效和安全性更新的荟萃分析。
Ren Fail 2023-09-23
The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors.
慢性腎臟病患者的貧血治療之旅:從紅細胞生成素到缺氧誘導因子-脯氨酸羟化酶抑制劑。
Clin Kidney J 2023-10-03
Iron Supplements Concomitant within Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitors in the Treatment of Chronic Kidney Disease Anemia.
慢性腎臟病貧血治療中與缺氧誘導因子脯氨酸羟化酶區域抑制劑同時使用的鐵補充劑。
Kidney Dis (Basel) 2023-12-16
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.
慢性腎臟病貧血的缺氧誘導因子脯氫化酶抑制劑:歐洲腎臟最佳實踐委員會文件。
Nephrol Dial Transplant 2024-04-04
Stabilizing Hypoxia-Inducible Factor to Manage Anemia in Chronic Kidney Disease: From Basic Theory to Clinical Study.
穩定低氧誘導因子以管理慢性腎臟病貧血:從基本理論到臨床研究。
Kidney Dis (Basel) 2024-04-25
Protein Bound Uremic Toxins and Inflammation Process in Hemodialysis Patients: is there a Role for Adsorption Hemodiafiltration?
血液透析患者中的蛋白質結合尿毒素與炎症過程:吸附性血液透析過濾是否有其作用?
Blood Purif 2024-07-24